PRNewswire Bangalore Karnataka [India] November 12 Alliance University South India first private institution recognized by ...

The slower cycle still allows the cell to divide, but the new cells often struggle to ... Acute multi-level response to defective de novo chromatin assembly in S-phase. Jan Dreyer*, Giulia Ricci*, ...

Alliance University’s commitment to research and innovation is evident through its Research Council, competitive research ...

About one-third of cases are diagnosed at late stages when the disease is hard to treat ... When a particular gene that ...

“We were pleased to report initial safety and efficacy data from twelve patients with advanced solid tumors enrolled in the Phase 2 part of the 065-101 ... innovative cancer medicines based on cell ...

For the Immunocompromised/Stem Cell Transplant patient trial, additional sites have been added and patient enrollment continues. Activities underway in support of Phase 2 study of Gedeptin ...

My name is Kelsey, and I will be your Zoom operator today. We thank you all for your attendance today. And as a reminder, this webinar is being recorded. And now, I would like to turn the call over to ...

The 2025 Global Private Equity Outlook provides dealmakers with key insights as they look to raise funds, deploy capital, and get back to the deal table over the next twelve months. 60% of respondents ...

The N-AVD regimen showed improved progression-free survival and lower toxicity than BV-AVD in advanced Hodgkin lymphoma, ...

with minimal change in manufacturing protocol across each phase. The NMU is 21 CFR Part 11 compliant ... Nutcracker Therapeutics' unique scalable RNA platform significantly reduces costs and cycle ...

Researchers from the Mattiroli group have found that the way DNA is packaged in cells can directly impact how fast DNA itself ...